US Patent Issued to INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) Paris FRANCE, UNIVERSITE DE NANTES on Nov. 11 for "Mutated interleukin-34 (IL-34) polypeptides and uses thereof in therapy" (French Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,466,866, issued on Nov. 11, was assigned to INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) Paris FRANCE (Paris) and UNIVERSITE DE NANTES (Nantes, France).

"Mutated interleukin-34 (IL-34) polypeptides and uses thereof in therapy" was invented by Carole Guillonneau (La Chevroliere, France), Ignacio Anegon (Nantes, France), Erwan Mortier (Nantes, France) and Agnes Quemener (Nantes, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "Interleukin-34 is a cytokine that is involved in the differentiation and survival of macrophages, monocytes, and dendritic cells in response to inflammation. The involvement of IL-34 has been shown in area...